Cancer Malignancy Is Enhanced by Glyceraldehyde-Derived Advanced Glycation End-Products

Figure 2

Cell viability was determined using the WST-1 assay. (a) Cells were incubated with control unglycated BSA or Glycer-AGEs for 48 h. The shaded, open, and filled bars represent the results for cells treated with PBS, control unglycated BSA, and Glycer-AGEs, respectively. (b) Cells were incubated with control unglycated BSA or Glycer-AGEs (100 $\mu$g/ml) for 48 and 72 h. Data are shown as the mean $\pm$ SD (n $=$ 6) ${}^{**}P\mathrm{\hspace{0.17em}\hspace{0.17em}}<\mathrm{\hspace{0.17em}\hspace{0.17em}}.01$ versus PBS, ${}^{\#\#}P\mathrm{\hspace{0.17em}\hspace{0.17em}}<\mathrm{\hspace{0.17em}\hspace{0.17em}}.01$ versus 48 h.

(a)

(b)